INHIBITION OF VASOPRESSIN-STIMULATED FLANK MARKING BEHAVIOR BY V1-RECEPTOR ANTAGONISTS

被引：67
作者：
FERRIS, CF
SINGER, EA
MEENAN, DM
ALBERS, HE
机构：
[1] VIENNA UNIV, INST PHARMACOL, A-1010 VIENNA, AUSTRIA
[2] GEORGIA STATE UNIV, DEPT BIOL, NEUROENDOCRINOL & BEHAV, ATLANTA, GA 30303 USA
[3] GEORGIA STATE UNIV, DEPT PSYCHOL, ATLANTA, GA 30303 USA
来源：
EUROPEAN JOURNAL OF PHARMACOLOGY | 1988年 / 154卷 / 02期
关键词：
D O I：
10.1016/0014-2999(88)90092-1
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：153 / 159
页数：7
相关论文
共 21 条
  • [11] INHIBITION OF FLANK-MARKING BEHAVIOR IN GOLDEN-HAMSTERS BY MICROINJECTION OF A VASOPRESSIN ANTAGONIST INTO THE HYPOTHALAMUS
    FERRIS, CF
    POLLOCK, J
    ALBERS, HE
    LEEMAN, SE
    [J]. NEUROSCIENCE LETTERS, 1985, 55 (02) : 239 - 243
  • [12] BIOLOGICAL EVALUATION OF SUBSTANCE-P ANTAGONISTS
    FOLKERS, K
    HAKANSON, R
    HORIG, J
    CHENG, XJ
    LEANDER, S
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1984, 83 (02) : 449 - 456
  • [13] PROPERTIES OF RAT ANTERIOR-PITUITARY VASOPRESSIN RECEPTORS - RELATION TO ADENYLATE-CYCLASE AND THE EFFECT OF CORTICOTROPIN-RELEASING FACTOR
    GAILLARD, RC
    SCHOENENBERG, P
    FAVRODCOUNE, CA
    MULLER, AF
    MARIE, J
    BOCKAERT, J
    JARD, S
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (09): : 2907 - 2911
  • [14] JOHNSTON R E, 1975, Zeitschrift fuer Tierpsychologie, V37, P75
  • [15] INTERACTION OF RAT ADENOHYPOPHYSEAL VASOPRESSIN RECEPTORS WITH VASOPRESSIN ANALOGS SUBSTITUTED AT POSITIONS 7 AND 1 - DISSIMILARITY FROM THE V1 VASOPRESSIN RECEPTOR
    KNEPEL, W
    GOTZ, D
    FAHRENHOLZ, F
    [J]. NEUROENDOCRINOLOGY, 1986, 44 (03) : 390 - 396
  • [16] ARGININE VASOPRESSIN AND A VASOPRESSIN ANTAGONIST PEPTIDE - OPPOSITE EFFECTS ON EXTINCTION OF ACTIVE-AVOIDANCE IN RATS
    KOOB, GF
    LEMOAL, M
    GAFFORI, O
    MANNING, M
    SAWYER, WH
    RIVIER, J
    BLOOM, FE
    [J]. REGULATORY PEPTIDES, 1981, 2 (03) : 153 - 163
  • [17] CENTRAL INJECTIONS OF ARGININE VASOPRESSIN PROLONG EXTINCTION OF ACTIVE-AVOIDANCE
    KOOB, GF
    DANTZER, R
    BLUTHE, RM
    LEBRUN, C
    BLOOM, FE
    LEMOAL, M
    [J]. PEPTIDES, 1986, 7 (02) : 213 - 218
  • [18] [1-(BETA-MERCAPTO-BETA,BETA-CYCLOPENTAMETHYLENEPROPIONIC ACID),2-(O-METHYL)TYROSINE]ARGININE-VASOPRESSIN AND [1-(BETA-MERCAPTO-BETA,BETA-CYCLOPENTAMETHYLENEPROPIONIC ACID)]ARGININE-VASOPRESSIN, 2 HIGHLY POTENT ANTAGONISTS OF THE VASOPRESSOR RESPONSE TO ARGININE-VASOPRESSIN
    KRUSZYNSKI, M
    LAMMEK, B
    MANNING, M
    SETO, J
    HALDAR, J
    SAWYER, WH
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1980, 23 (04) : 364 - 368
  • [19] VASOPRESSIN PRESSOR ANTAGONIST INJECTED CENTRALLY REVERSES BEHAVIORAL-EFFECTS OF PERIPHERAL INJECTION OF VASOPRESSIN, BUT ONLY AT DOSES THAT REVERSE INCREASE IN BLOOD-PRESSURE
    LEBRUN, C
    LEMOAL, M
    KOOB, GF
    BLOOM, FE
    [J]. REGULATORY PEPTIDES, 1985, 11 (02) : 173 - 181
  • [20] SUBSTANCE P-ANTAGONISTS - A NEW TYPE OF PHARMACOLOGICAL TOOL
    ROSELL, S
    FOLKERS, K
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1982, 3 (05) : 211 - 212
123